Acute disseminated encephalomyelitis cost-effectiveness of therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]
Overview
Unlike Multiple Sclerosis, studies regarding the cost-effectiveness of therapeutic options are lacking for Acute disseminated encephalomyelitis.
Cost-Effectiveness of Therapy
Unlike Multiple Sclerosis, studies regarding the cost-effectiveness of therapeutic options are lacking for Acute disseminated encephalomyelitis.
References
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH